{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:53:08Z","timestamp":1787320388713,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":3632,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jpain.2013.05.010","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T10:00:45Z","timestamp":1373450445000},"page":"1227-1241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Comparison of the Risks of Opioid Abuse or Dependence Between Tapentadol and Oxycodone: Results From a Cohort Study"],"prefix":"10.1016","volume":"14","author":[{"given":"M. Soledad","family":"Cepeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2013.05.010_bib1","unstructured":"American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine. Definitions related to the use of opioids for the treatment of pain: consensus statement. http:\/\/www.asam org\/advocacy\/find-a-policy-statement\/view-policy-statement\/public-policy-statements\/2011\/12\/15\/definitions-related-to-the-use-of-opioids-for-the-treatment-of-pain-consensus-statement 2001"},{"key":"10.1016\/j.jpain.2013.05.010_bib2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1517\/14656566.2010.497720","article-title":"Efficacy and safety of tapentadol extended release for the\u00a0management of chronic low back pain: Results of\u00a0a\u00a0prospective, randomized, double-blind, placebo- and active-controlled phase III study","volume":"11","author":"Buynak","year":"2010","journal-title":"Exp Opin Pharmacother"},{"key":"10.1016\/j.jpain.2013.05.010_bib3","first-page":"10","article-title":"CDC grand rounds: Prescription drug overdoses\u2014A U.S. epidemic","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpain.2013.05.010_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-684X-9-14","article-title":"Dose patterns in commercially insured subjects chronically exposed to opioids: A large cohort study in the United States","volume":"9","author":"Cepeda","year":"2010","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jpain.2013.05.010_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1099-1557(200003\/04)9:2<103::AID-PDS477>3.0.CO;2-6","article-title":"The use of propensity scores in pharmacoepidemiologic research","volume":"9","author":"Cepeda","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpain.2013.05.010_bib6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/aje\/kwg115","article-title":"Comparison of\u00a0logistic regression versus propensity score when the number of events is low and there are multiple confounders","volume":"158","author":"Cepeda","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jpain.2013.05.010_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11596600-000000000-00000","article-title":"Assessing opioid shopping behaviour: A large cohort study from a medication dispensing database in the US","volume":"35","author":"Cepeda","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.jpain.2013.05.010_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/0091270012436561","article-title":"Opioid shopping behavior: How often, how soon, which drugs, and what payment method","volume":"53","author":"Cepeda","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jpain.2013.05.010_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpain.2012.10.012","article-title":"Comparison of opioid doctor shopping for tapentadol and oxycodone: A cohort study","volume":"14","author":"Cepeda","year":"2013","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2013.05.010_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: Concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2013.05.010_bib11","unstructured":"Dart R, Bucher-Bartelson B, Adams EH. Non-medical use of tapentadol immediate release by college students. American Academy of Pain Medicine (AAPM) Annual Meeting. Palm Springs, CA. February 2012. http:\/\/www.painmed.org\/2012posters\/abstract-271. Accessed May 16, 2013"},{"key":"10.1016\/j.jpain.2013.05.010_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5055\/jom.2012.0139","article-title":"Assessment of the abuse of tapentadol immediate release: The first 24 months","volume":"8","author":"Dart","year":"2012","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.jpain.2013.05.010_bib13","first-page":"1078","article-title":"Post-marketing surveillance of methadone and buprenorphine in the United States","volume":"11","author":"Dasgupta","year":"2010","journal-title":"Pain\u00a0Med"},{"key":"10.1016\/j.jpain.2013.05.010_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10742-012-0102-1","article-title":"Applying standardized drug terminologies to observational healthcare databases: A case study on opioid exposure","volume":"13","author":"DeFalco","year":"2013","journal-title":"Health Serv Outcomes Res Methodol"},{"key":"10.1016\/j.jpain.2013.05.010_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2010.05.017","article-title":"Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP study","volume":"112","author":"Edlund","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2013.05.010_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pain.2007.02.014","article-title":"Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain","volume":"129","author":"Edlund","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2013.05.010_bib17","series-title":"Relieving pain in America: A blueprint for transforming prevention, care, education, and research","year":"2011"},{"key":"10.1016\/j.jpain.2013.05.010_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1198\/004017007000000245","article-title":"Large-scale Bayesian logistic regression for text categorization","volume":"49","year":"2007","journal-title":"Technometrics"},{"key":"10.1016\/j.jpain.2013.05.010_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ejpain.2010.06.017","article-title":"Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally-acting analgesics on the horizon?","volume":"14","author":"Kress","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpain.2013.05.010_bib20","first-page":"249","article-title":"Opioid prescriptions soar: increase in legitimate use as well as abuse","volume":"297","author":"Kuehn","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2013.05.010_bib21","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jpain.2013.05.010_bib22","unstructured":"Love LA: Recommendations regarding the abuse potential of tapentadol. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/022304s000_OtherR.pdf 2008 Available\u00a0from: URL: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/022304s000_OtherR.pdf"},{"key":"10.1016\/j.jpain.2013.05.010_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","article-title":"Systematic review: Opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction","volume":"146","author":"Martell","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpain.2013.05.010_bib24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwr364","article-title":"Effects of adjusting for instrumental variables on bias and precision of effect estimates","volume":"174","author":"Myers","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jpain.2013.05.010_bib25","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/j.1475-6773.2005.00444.x","article-title":"Measuring diagnoses: ICD code accuracy","volume":"40","author":"O'Malley","year":"2005","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jpain.2013.05.010_bib26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MLR.0b013e31824ebd81","article-title":"Doctor and pharmacy shopping for controlled substances","volume":"50","author":"Peirce","year":"2012","journal-title":"Med Care"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2013.05.010_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pds.2328","article-title":"Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system","volume":"21","author":"Rassen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpain.2013.05.010_bib28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jbi.2012.05.002","article-title":"Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases","volume":"45","author":"Reich","year":"2012","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jpain.2013.05.010_bib29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jama.1988.03720040047025","article-title":"Clarification and standardization of substance abuse terminology","volume":"259","author":"Rinaldi","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2013.05.010_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.jpain.2013.05.010_bib31","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jama.2012.234","article-title":"Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan","volume":"307","author":"Seal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2013.05.010_bib32","doi-asserted-by":"crossref","first-page":"d7403","DOI":"10.1136\/bmj.d7403","article-title":"The painful truth: Deaths and misuse of prescribed drugs","volume":"343","author":"Spence","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jpain.2013.05.010_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: A\u00a0review and a look forward","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"key":"10.1016\/j.jpain.2013.05.010_bib34","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwq198","article-title":"Treatment effects in the presence of unmeasured confounding: Dealing with observations in the tails of the propensity score distribution\u2014A simulation study","volume":"172","author":"Sturmer","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jpain.2013.05.010_bib35","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2006 national survey on drug use and health: National findings. 2007. Available at: http:\/\/www.oas.samhsa.gov\/nsduh\/2k6nsduh\/2k6Results.pdf"},{"key":"10.1016\/j.jpain.2013.05.010_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archinternmed.2011.101","article-title":"Limiting the potential harms of high-dose opioid therapy: Comment on \u201cOpioid dose and drug-related mortality in patients with nonmalignant pain.\u201d","volume":"171","author":"Sullivan","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpain.2013.05.010_bib37","unstructured":"Surrat HL, Kurtz SP, Cicero TJ, Dart RC: Street prices of prescription opioids diverted to the illicit market. 12 A.D. Jun 9; 2012"},{"key":"10.1016\/j.jpain.2013.05.010_bib38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/AJP.0b013e31816b1070","article-title":"Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis","volume":"24","author":"Turk","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2013.05.010_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.107.126052","article-title":"(\u2013)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): A novel mu-opioid receptor agonist\/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties","volume":"323","author":"Tzschentke","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2013.05.010_bib40","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/jama.2011.369","article-title":"Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment","volume":"305","author":"Volkow","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2013.05.010_bib41","first-page":"897","article-title":"Analytic models to identify patients at risk for prescription opioid abuse","volume":"15","author":"White","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jpain.2013.05.010_bib42","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(03)00003-6","article-title":"College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: Position statement","volume":"69","author":"Zacny","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpain.2013.05.010_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12264-012-1206-x","article-title":"Interaction and regulatory functions of\u00a0mu- and delta-opioid receptors in nociceptive afferent neurons","volume":"28","author":"Zhang","year":"2012","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.jpain.2013.05.010_bib44","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1523\/JNEUROSCI.5968-09.2010","article-title":"Synaptic mechanism for functional synergism between \u03b4 and \u03c5 opioid receptors","volume":"30","author":"Zhang","year":"2010","journal-title":"J Neurosci"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590013010511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590013010511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:57:17Z","timestamp":1761508637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590013010511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1526590013010511"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2013.05.010","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Risks of Opioid Abuse or Dependence Between Tapentadol and Oxycodone: Results From a Cohort Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2013.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}